Alicia Mundy Views
On Friday, the WSJ printed a story by Alicia Mundy, Health-Bill Disclosure Rule Is Resisted, which revealed that a recently passed health-reform bill in the House would require drug companies to disclose payments made to physicians and third parties, such as medical education communications companies, or MECCs. But the idea is nothing new, and reports of such disclosures have been carried extensively by various news sources, including the WSJ and the related WSJ Health Blog.
Alicia Mundy is the Washington Bureau Chief for Mediaweek and a contributing editor at Washingtonian magazine. Her feature stories have appeared in US News and World Report, GQ, Philadelphia Magazine, The Wall Street Journal, and The Washington Post. Mundy is the winner of several journalism awards for commentary and investigative reporting. She lives in Alexandria, Virginia.
The Barnes Noble Review In the tradition of the bestselling A Civil Action, journalist Alicia Mundy presents the dramatic story of the health crisis brought on by the diet-drug combination called Fen-Phen in the late 1990s. Thousands of women were suddenly stricken, and many of them died -- some quickly -- while others suffered for years before perishing. Those who didn't die suffered severe damage to their heart and lungs. It was discovered that one half of the drug combination -- marketed and sold by a huge pharmaceutical company called Wyeth-Ayerst -- was to blame. The question was: How much did the drug company know about the risk factor of their product -- and why hadn't they alerted the FDA and the medical establishment? (Nicholas Sinisi)
Investigative journalist Alicia Mundy discusses her new book about the medical and legal controversies surrounding the diet drug l"fen-phen.o" When it was first introduced, it was hailed as an important new weapon in the fight against obesity - but thousands of the people who took it developed dangerous and sometimes fatal heart and lung illnesses.
Alicia Mundy Images
